PWPS
TGTX icon

Pinnacle Wealth Planning Services’s TG Therapeutics TGTX Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$168K Buy
3,065
+242
+9% +$9.9K 0.02% 604
2026
Q1 		$93.8K Buy
2,823
+834
+42% +$24.9K 0.01% 837
2025
Q4 		$59.3K Buy
+1,989
New +$65K 0.01% 1090
2021
Q1 		– Sell
-547
Closed -$28K – 1776
2020
Q4 		$28K Buy
+547
New +$18.5K 0.01% 1026

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Pinnacle Wealth Planning Services's TGTX Position: Q2 2026 in Review

Pinnacle Wealth Planning Services increased its TG Therapeutics (TGTX) stake by 8.6% in Q2 2026, buying an estimated $9.9K and bringing the position to 3,065 shares worth $168K. The position accounts for 0.02% of the portfolio, ranked #604.

Pinnacle Wealth Planning Services first reported a position in TGTX in Q4 2020 and has held it in 4 quarters since. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Pinnacle Wealth Planning Services held 3,065 shares of TG Therapeutics worth $168K as of Q2 2026.
  • Pinnacle Wealth Planning Services bought 242 TG Therapeutics shares in Q2 2026, an estimated $9.9K.
  • TG Therapeutics made up 0.02% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #604 holding.
  • Pinnacle Wealth Planning Services first reported a position in TG Therapeutics in Q4 2020 and has held it in 4 quarters since.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.